Autoantibodies recognizing native MOG are closely associated with active demyelination but not with neuroinflammation in chronic EAE

Neuropathology

Volumn 31, Issue 2, 2011, Pages 101-111

  Ohtani, Shin ^a   Kohyama, Kuniko ^a   Matsumoto, Yoh ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Conformational epitope; Experimental autoimmune encephalomyelitis; Myelin oligodendrocyte glycoprotein; Relapse; Secondary progression

Indexed keywords

AUTOANTIBODY; GLYCOSYLATED PROTEIN; MONOCLONAL ANTIBODY R73; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DEMYELINATION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; DEMYELINATING DISEASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; MYELIN-ASSOCIATED GLYCOPROTEIN; RATS;

EID: 78649446529     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2010.01131.x     Document Type: Article

References (26)

1. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 46: 907-911.
2. O'Connor KC, Ray SM, Becker CH, Hafler DA. Comprehensive phenotyping in multiple sclerosis; discovery based proteomics and the current understanding of putative biomarkers. Disease Markers 2006; 22: 213-225.
3. Harris VK, Sadiq SA. Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making. Mol Diagn Ther 2009; 13: 225-244.
4. Chiasserini D, Di Filippo M, Candeliere A etal. CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis. Eur J Neurol 2008; 15: 998-1001.
5. Tumani H, Lehmensiek V, Rau D etal. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis. Neurosci Lett 2009; 452: 214-217.
6. Liu T, Donahue KC, Hu J etal. Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord. J Proteome Res 2007; 6: 2565-2575.
7. Han MH, Hwang SI, Roy DB etal. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 2008; 451: 1076-1081.
8. Berger T, Rubner P, Schautzer F etal. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 2003; 349: 139-145.
9. Lampasona V, Franciotta D, Furlan R etal. Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects. Neurology 2004; 62: 2092-2094.
10. Kuhle J, Pohl C, Mehling M etal. Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med 2007; 356: 371-378.
11. von Budingen HC, Hauser SL, Fuhrmann A, Nabavi CB, Lee JI, Genain CP. Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination. Proc Natl Acad Sci USA 2002; 99: 8207-8212.
12. von Budingen HC, Hauser SL, Ouallet JC, Tanuma N, Menge T, Genain CP. Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination. Eur J Immunol 2004; 34: 2072-2083.
13. Lalive PH, Menge T, Delarasse C etal. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Proc Natl Acad Sci USA 2006; 103: 2280-2285.
14. Zhou D, Srivastava R, Nessler S etal. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc Natl Acad Sci USA 2006; 103: 19057-19062.
15. Sakuma H, Kohyama K, Park IK, Miyakoshi A, Tanuma N, Matsumoto Y. Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats. Brain 2004; 127: 2201-2213.
16. Deibler GE, Martenson RE, Kies MW. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep Biochem 1972; 2: 139-165.
17. Storch MK, Stefferl A, Brehm U etal. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 1998; 8: 681-694.
18. Matsumoto Y, Fujiwara M. The immunopathology of adoptively transferred experimental allergic encephalomyelitis (EAE) in Lewis rats. Part 1. Immunohistochemical examination of developing lesion of EAE. J Neurol Sci 1987; 77: 35-47.
19. Ohmori K, Hong Y, Fujiwara M, Matsumoto Y. In situ demonstration of proliferating cells in the rat central nervous system during experimental autoimmune encephalomyelitis. Evidence suggesting that most infiltrating T cells do not proliferate in the target organ. Lab Invest 1992; 66: 54-62.
20. Brunner C, Lassmann H, Waehneldt TV, Matthieu JM, Linington C. Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2', 3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats. J Neurochem 1989; 52: 296-304.
21. O'Connor KC, McLaughlin KA, De Jager PL etal. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med 2007; 13: 211-217.
22. Vollers SS, Stern LI. Class II major histocompatibility complex tetramer staining: progress, problems, and prospects. Immunology 2008; 123: 305-313.
23. von Budingen HC, Hauser SL, Ouallet JC, Tanuma N, Menge T, Genain CP. Frontline: epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination. Eur J Immunol 2004; 34: 2072-2083.
24. Linington C, Bradl M, Lassmann H, Brunner C, Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 1988; 130: 443-454.
25. Urich E, Gutcher I, Prinz M, Becher B. Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors. Proc Natl Acad Sci USA 2006; 103: 18697-18702.
26. Marta CB, Oliver AR, Sweet RA, Pfeiffer SE, Ruddle NH. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc Natl Acad Sci USA 2005; 102: 13992-13997.